Organisation paid for research Program year 2025 Source: CMS Open Payments

Amr Dearborn

Neither a doctor nor a teaching hospital

Research payments

$66,925

61 payments

Through program year 2025, Amr Dearborn is reported as receiving $66,925 in research payments, across 61 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$42,098	57
2024	Research	$24,827	4

Breakdown

Who paid Research payments · program years 2024–2025

Boehringer Ingelheim International GmbH $42,057 56 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $24,868 5 payments

Studies the money was for Research payments · program years 2024–2025

EASi-HF A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) $42,098 57 payments
BI 690517+Empa - Placebo+Empa in patients w. HF (LVEF) $24,827 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.